XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Parent
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Deferred Compensation Employee Stock Trust, Net
Employee Stock Trust
Noncontrolling Interest
Total
Balance at Dec. 31, 2021 $ 2,522,668 $ 790 $ 1,274,446 $ (10,219) $ 1,257,014 $ 752 $ (115) $ 26,535 $ 2,549,203
Balance (in shares) at Dec. 31, 2021   78,965,000         6,000    
Increase (Decrease) in Stockholders' Equity                  
Net income 22,250       22,250     1,889 24,139
Other comprehensive loss (70,346)     (70,346)         (70,346)
Stock-based compensation expense 5,114   5,114           5,114
Common stock issued to board members 152   152           152
Common stock issued to board members (in shares)   5,000              
Issuance of common stock related to share-based awards, net (4,059) $ 4 (4,063)           (4,059)
Issuance of common stock related to share-based awards, net (in shares)   469,000              
Dividends on common stock (11,849)       (11,849)       (11,849)
Deferred compensation plan 3         (8) $ 11   3
Deferred compensation plan (in shares)             (1,000)    
Net cash distributed to noncontrolling interest               (1,762) (1,762)
Balance at Mar. 31, 2022 2,463,933 $ 794 1,275,649 (80,565) 1,267,415 744 $ (104) 26,662 2,490,595
Balance (in shares) at Mar. 31, 2022   79,439,000         5,000    
Balance at Dec. 31, 2022 2,036,924 $ 647 1,046,331 (133,531) 1,123,636 481 $ (640) 26,605 2,063,529
Balance (in shares) at Dec. 31, 2022   64,685,000         23,000    
Increase (Decrease) in Stockholders' Equity                  
Net income 25,800       25,800     1,968 27,768
Other comprehensive loss 8,070     8,070         8,070
Stock-based compensation expense 4,047   4,047           4,047
Common stock issued to board members 150   150           150
Common stock issued to board members (in shares)   5,000              
Issuance of common stock related to share-based awards, net (3,432) $ 5 (3,437)           (3,432)
Issuance of common stock related to share-based awards, net (in shares)   478,000              
Repurchases of common stock (4,503) $ (2) (2,317)   (2,184)       $ (4,503)
Repurchases of common stock (in shares)   (145,000)             (144,403)
Dividends on common stock (10,351)       (10,351)       $ (10,351)
Deferred compensation plan 6         (35) $ 41   6
Deferred compensation plan (in shares)             (2,000)    
Net cash distributed to noncontrolling interest               (1,486) (1,486)
Balance at Mar. 31, 2023 $ 2,056,711 $ 650 $ 1,044,774 $ (125,461) $ 1,136,901 $ 446 $ (599) $ 27,087 $ 2,083,798
Balance (in shares) at Mar. 31, 2023   65,023,000         21,000